5Katz PO, Gnsberg GG, Hoyle PE, et al. Relationship between intragastric acid control and healing status in the treatment of moderate to Aliment Phamacol Ther, 2007, 25. 被引量：1
6Heudebert GR, Marks R, Wilcox CM, et al. Choice of long-term strategy for the management of patients with severe esophagitis : accost-utility analysis [J]. Gastroenterology, 1997, 112(9): 1078-1086. 被引量：1
7Gastell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 rag) in the treatment of erosive esophgitis [J]. Am J Gastroenterol, 2002, 97(3): 575-583. 被引量：1
8Labenz J, Naucler E, Eklund S. A comparison of esomeprazole 40 mg once daily for the healing of reflux esophagitis [ J]. Gut, 2003, 52(1): 241. 被引量：1
9Miyamoto M, Haruma K, Takeuchi K, el al. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton inhibitor therapy [ J]. J Gastroenterol Hepatol, 2008, 23(5): 744-751. 被引量：1
10Scote LJ,Dunn CHJ.Esomeprazole:review of it's use in the manegement of acidrelated disorders in the use[J].Drugs,2002,62(7):1091-1118. 被引量：1
1de Vries DR, van Herwaarden MA, Smout AJ, et al. Gastroe- sophageal pressure gradients in gastroesophageal reflux dis- ease: relations with hiatal hernia, body mass index, and esopha- geal acid exposure[J]. Am J Gastroenterol,2008,103(6) ：1349- 1354. 被引量：1
